Skip to main content
. 2017 Jul 17;2:20. doi: 10.1038/s41541-017-0021-9

Fig. 4.

Fig. 4

Detection of reversion mutants of the MP-12 vaccine during viral passages in MRC-5 cells. The MP-12 vaccine was passaged 25 times in MRC-5 cells at MOI of 0.01 or less at 3 days post infection. Virus RNA was purified from culture supernatants and analyzed for the presence of reversion mutations using Taqman probes (shown in Supplementary Fig. 1 and Supplementary Table 2). a M-segment nt. 795: HEX-795-C and FAM-795-T, b M-segment nt. 3564: HEX-3564-G and FAM-3564-A, c L-segment nt. 533: HEX-533-C and FAM-533-T, d L-segment nt. 3104: HEX-3104-A and FAM-3104-G, and e L-segment nt. 3750: HEX-3750-A and FAM-3750-G. Three independent studies are shown (Exp-1, 2, and 3). Relative percentages of RNA copy numbers for parental and reversion mutants are shown in blue and red bars, respectively. The bar labels in red represent the percentages of reversion mutants